πŸ‡ΊπŸ‡Έ FDA
Patent

US 8822470

Substituted pyrido[2,3-b]pyrazines

granted A61KA61K31/4985A61K31/506

Quick answer

US patent 8822470 (Substituted pyrido[2,3-b]pyrazines) held by Takeda Pharmaceutical Company Limited expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4985, A61K31/506, A61K31/53, A61K31/5383